|
P01
|
Human Albumin |
10P-AL101 |
1.0 mg |
|
Purity > 99% by SDS-PAGE.
|
|
|
P01-a
|
Human Albumin |
10P-AL105 |
5.0 mg |
|
Purity >99% by SDS-PAGE
|
|
|
P03
|
Human Apo AI |
11P-101 |
1.0 mg |
|
Purity > 98% by SDS-PAGE.
|
|
|
P03-a
|
Human Apo AI |
11P-105 |
5.0 mg |
|
Purity > 98% by SDS-PAGE.
|
|
|
P05
|
Human Apo AII |
12P-105 |
0.5 mg |
|
Purity > 98% by SDS-PAGE
|
|
|
P05-a
|
Human Apo AII |
12P-110 |
1.0 mg |
|
Purity > 98% by SDS-PAGE
|
|
|
P07
|
Human Apo B-100 |
20P-B105 |
0.5 mg |
|
Purity > 98% by SDS-PAGE. Preserved with 50% glycerol.
|
|
|
P07-a
|
Human Apo B-100 |
20P-B110 |
1.0 mg |
|
Purity > 99% by SDS-PAGE. Preserved with 50% glycerol.
|
|
|
P11
|
Human Apo CI |
31P-102 |
0.2 mg |
|
Purity > 98% by SDS-PAGE.
|
|
|
P11-a
|
Human Apo CI |
31P-110 |
1 mg |
|
Purity > 98% by SDS-PAGE.
|
|
|
P11-b
|
Human Apo CI |
31P-105 |
0.5 mg |
|
Purity > 98% by SDS-PAGE.
|
|
|
P13
|
Human Apo CII |
32P-101 |
0.1 mg |
|
Purity ≥ 98% by SDS-PAGE.
|
|
|
P14
|
Human Apo CIII |
33P-102 |
0.20 mg |
|
Purity ≥ 98% by SDS-PAGE
|
|
|
P14-a
|
Human Apo CIII |
33P-105 |
0.50 mg |
|
Purity ≥ 98% by SDS-PAGE.
|
|
|
P14-b
|
Human Apo CIII |
33P-110 |
1.00 mg |
|
Purity ≥ 98% by SDS-PAGE.
|
|
|
P16
|
Human Apo E |
50P-101 |
0.1 mg |
|
Purity ≥ 98% by SDS-PAGE.
|
|
|
P10
|
Human C-Reactive Protein ( CRP ) |
30P-CRP105 |
0.5 mg |
|
Purity > 99% by SDS-PAGE
|
|
|
p10-a
|
Human C-Reactive Protein ( CRP ) |
30P-CRP110 |
1.0 mg |
|
Purity > 99% by SDS-PAGE
|
|
|
P18
|
Human HDL |
80P-HD101 |
1.0 mg |
|
Density 1.063 – 1.210. Preserved with 50% glycerol.
|
|
|
P18-b
|
Human High Density Lipoprotein 2 (HDL-2) |
80P-HD2-101 |
1.0 mg |
|
Density 1.063 – 1.120 Preserved with 50% glycerol.
|
|
|
P18-c
|
Human High Density Lipoprotein 3 (HDL-3) |
80P-HD3-101 |
1.0 mg |
|
Density 1.120 – 1.210 Preserved with 50% glycerol.
|
|
|
P08
|
Human LDL |
20P-L101 |
1.0 mg |
|
Density 1.03 – 1.063. Purity > 98% by SDS-PAGE. Preserved with 50% glycerol.
|
|
|
P08-a
|
Human LDL |
20P-L105 |
5.0 mg |
|
Density 1.03 – 1.063. Purity > 98% by SDS-PAGE. Preserved with 50% glycerol.
|
|
|
P02
|
Human LP(a) |
10P-LP101 |
0.1 mg |
|
Purified by Lysine and Heparin-Sepharose
|
|
|
P17
|
Human Plasminogen |
60P-PG101 |
1.0 mg |
|
Purity ≥ 98% by SDS-PAGE.
|
|
|
P09
|
Human VLDL |
22P-VL101 |
1.0 mg |
|
Density 1.006. Preserved with 50% glycerol.
|
|
|
P09-a
|
Human VLDL |
22P-VL105 |
5.0 mg |
|
Density 1.006. Preserved with 50% glycerol.
|
|
|
P15-b
|
Ulta Pure ApoCIII |
33P-UP210 |
1.0 mg |
|
Purity ≥ 99% by SDS-PAGE.
|
|
|
P15
|
Ultra Pure Apo CIII |
33P-UP202 |
0.20 mg |
|
Purity ≥ 99% by SDS-PAGE.
|
|
|
P15-a
|
Ultra Pure Apo CIII |
33P-UP205 |
0.50 mg |
|
Purity ≥ 99% by SDS-PAGE.
|
|
|
P04
|
Ultra Pure Human Apo AI |
11P-UP205 |
0.5 mg |
|
Purity > 99% by SDS-PAGE
|
|
|
P04-a
|
Ultra Pure Human Apo AI |
11P-UP210 |
1.0 mg |
|
Purity > 99% by SDS-PAGE
|
|
|
P06
|
Ultra Pure Human Apo AII |
12P-UP205 |
0.5 mg |
|
Purity > 99% by SDS-PAGE
|
|
|
P06-a
|
Ultra Pure Human Apo AII |
12P-UP210 |
1.0 mg |
|
Purity > 99% by SDS-PAGE
|
|
|
P12-a
|
Ultra Pure Human Apo CI |
31P-UP202 |
0.2 mg |
|
Purity > 99% by SDS-PAGE.
|
|